Vernakalant versus Amiodarone for post-operative atrial fibrillation in Cardiac Surgery Patients


This study is comparing two different anti-arrhythmic agents in patients that develop atrial fibrillation soon after cardiac surgery.


Currently recruiting participants: Yes

Eligible gender: Male, Female, Transgender, Other

Eligible ages: 18 to 100

Inclusion criteria:

Patients 18 years or older who have coronary bypass surgery or valve repair/replacement.

Exclusion criteria:

1) Patients who are too sick and unstable after surgery
2) Mechanical valves or ventricular assist device
3) Atrial fibrillation ablation (MAZE) during cardiac surgery
4) History of atrial fibrillation in the past
5) Abnormal ECG parameters
6) Allergies to vernkalant or amiodarone
7) Major liver or lung disease


This study is not currently accepting expressions of interest via the website. Please see contact information below.

Additional information

Contact information

Through hospital admission

Principal investigator:

Vikas Kuriachan

Clinical trial: